InspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the InspireMD Third Quarter 2024 Earnings Call. Currently, all participants are in a listen-only mod e.
Inspiremd Inc. (NSPR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 2,133,405 | $5,610,855 | 0.11% | |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,860,405 | $4,874,261 | 0% | |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,674,565 | $4,404,106 | -25% | 0.18% |
| 4. | Soleus Capital Guy Levy | 1,378,128 | $3,624,477 | 0.22% | |
| 5. | Velan Capital Adam Morgan | 904,029 | $2,377,596 | 2.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.53 | 50,000 | Director | 438,902 | 2023-11-30 | Filing | |
| $1.63 | 175,000 | Director | 248,534 | 2023-05-12 | Filing | |
| $1.63 | 61,249 | Director | 108,590 | 2023-05-12 | Filing | |
| $1.63 | 122,497 | Director | 122,497 | 2023-05-12 | Filing | |
| $1.63 | 61,249 | Director | 233,545 | 2023-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.18 | 65 | Director | 12,746 | 2018-12-11 | Filing | |
| $0.21 | 8 | Director | 0 | 2018-11-21 | Filing | |
| $2.64 | 597,300 | Director | 1,925,110 | 2013-11-26 | Filing | |
| $2.63 | 1,100 | Director | 2,522,410 | 2013-11-21 | Filing | |
| $2.68 | 1,000 | Director | 2,523,510 | 2013-11-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,495,783 | $6,563,909 | 3.35% | |
| 2. | 189,122 | $497,391 | 0.11% | |
| 3. | 124,301 | $326,912 | 0% | |
| 4. | 72,565 | $190,846 | 0.03% | |
| 5. | 48,022 | $126,298 | 0% |
News See All
InspireMD, Inc. (NASDAQ:NSPR) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the InspireMD Second Quarter 2024 Earnings Call. Currently, all participants' are in a listen-only mode.
InspireMD, Inc. (NASDAQ:NSPR) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the InspireMD First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript
InspireMD, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.2. InspireMD, Inc.
InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript
InspireMD, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.2.
InspireMD, Inc. (NASDAQ:NSPR) Q3 2023 Earnings Call Transcript
Operator: Good morning. And welcome to the InspireMD Third Quarter of 2023 Earnings Call. Currently, all participants are in a listen-only mode.
InspireMD, Inc. (NASDAQ:NSPR) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the InspireMD Second Quarter 2023 Earnings Call. Currently all participants are in a listen-only mode.
InspireMD, Inc. (NASDAQ:NSPR) Q1 2023 Earnings Call Transcript
Operator: Good day, and welcome to the InspireMD First Quarter 2023 Earnings Call. All participants will be in listen-only mode. [Operator Instructions].
InspireMD, Inc. (NASDAQ:NSPR) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the InspireMD Fourth Quarter and Full Year 2022 Earnings Call. Please note, this conference is being recorded.
InspireMD, Inc. (NASDAQ:NSPR) Q3 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the InspireMD Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
